September 2, 2024Frontiers in Cardiovascular Medicine15 citationsOpen Access
Circulating extracellular vesicles as biomarkers in the diagnosis, prognosis and therapy of cardiovascular diseases
Key Result
Circulating extracellular vesicles and their cargo show significant potential as diagnostic and prognostic biomarkers across various cardiovascular diseases.
Structured PICO
I
Intervention
Circulating extracellular vesicles (EV) as biomarkers and therapeutics
Circulating extracellular vesicles hold promise as biomarkers and therapeutics in cardiovascular disease, but clinical translation remains challenging.
Limitations
- Translation of EV studies to a preclinical or clinical setting has proven to be challenging
Abstract
models, EV also showed promising therapeutic potential. However, translation of EV studies to a preclinical or clinical setting has proven to be challenging. This review is intended to provide an overview of the most relevant studies in the field of serum or plasma-derived EV.